MARKET

LLY

LLY

Lilly
NYSE

Real-time Quotes | Nasdaq Last Sale

230.17
-1.47
-0.63%
After Hours: 230.00 -0.17 -0.07% 18:36 09/21 EDT
OPEN
232.06
PREV CLOSE
231.64
HIGH
233.72
LOW
229.74
VOLUME
2.17M
TURNOVER
--
52 WEEK HIGH
275.87
52 WEEK LOW
129.21
MARKET CAP
220.18B
P/E (TTM)
34.59
1D
5D
1M
3M
1Y
5Y
Factbox-Latest on the worldwide spread of the coronavirus
Johnson & Johnson said on Tuesday a second shot of its COVID-19 vaccine given about two months after the first increased its effectiveness to 94% in the United States against moderate to severe forms of the disease.
Reuters · 6h ago
Lilly To Supply EU, EEA With Up To 220,000 Doses Of AbCellera-Discovered Bamlanivimab Together With Etesevimab For Treatment Of Confirmed COVID-19
AbCellera (NASDAQ:ABCL) today announced the European Commission (EC) and Eli Lilly and Company (Lilly) have entered into a Joint Procurement Agreement to supply up to 220,000 doses of bamlanivimab together with
Benzinga · 9h ago
Lilly Confirms Earlier Report Co Won Procurement Agreement With European Commission To Supply Bamlanivimab And Estesevimab Together For Treatment Of Confirmed COVID-19
Eli Lilly and Company (NYSE:LLY) today announced a Joint Procurement Agreement with the European Commission (EC) to supply up to 220,000 doses of bamlanivimab and etesevimab for the treatment of confirmed COVID-19 in
Benzinga · 10h ago
Lilly announces procurement agreement with European Commission to supply bamlanivimab and etesevimab together for the treatment of confirmed COVID-19
Eli Lilly and Company (NYSE: LLY) today announced a Joint Procurement Agreement with the European Commission (EC) to supply up to 220,000 doses of bamlanivimab and etesevimab for the treatment of confirmed COVID-19 in patients aged 12 years and older who d...
PR Newswire · 10h ago
European Commission Signs Contract With Eli Lilly For Supply Of A Monoclonal Antibody Treatment
-Reuters
Reuters · 11h ago
Do Eli Lilly's (NYSE:LLY) Earnings Warrant Your Attention?
It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...
Simply Wall St. · 13h ago
BRIEF-Lilly Announces Early Tender Results Of Pending Cash Tender Offer
reuters.com · 15h ago
Eli Lilly and Reports $2 Billion Tender Offer Results
MT Newswires · 19h ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of LLY. Analyze the recent business situations of Lilly through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 21 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average LLY stock price target is 266.30 with a high estimate of 315.00 and a low estimate of 202.00.
EPS
Institutional Holdings
Institutions: 2.45K
Institutional Holdings: 840.36M
% Owned: 87.85%
Shares Outstanding: 956.58M
TypeInstitutionsShares
Increased
695
19.67M
New
178
7.52M
Decreased
735
20.32M
Sold Out
92
1.47M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
+0.40%
Pharmaceuticals & Medical Research
+0.74%
Key Executives
Chairman/President/Chief Executive Officer/Director
David Ricks
Chief Financial Officer/Senior Vice President
Anat Ashkenazi
Senior Vice President/Chief Information Officer
Aarti Shah
Senior Vice President/Chief Scientific Officer
Daniel Skovronsky
Senior Vice President/Chief Compliance Officer
Melissa Barnes
Senior Vice President/General Counsel/Secretary
Anat Hakim
Senior Vice President/Director of Human Resources
Stephen Fry
Senior Vice President
Patrik Jonsson
Senior Vice President
Michael Mason
Senior Vice President
Johna Norton
Senior Vice President
Myles O'Neill
Senior Vice President
Leigh Pusey
Senior Vice President
Anne White
Senior Vice President
Ilya Yuffa
Senior Vice President
Alfonso Zulueta
Lead Director/Independent Director
Juan Luciano
Independent Director
Raul Alvarez
Independent Director
Katherine Baicker
Independent Director
Michael Eskew
Independent Director
J. Erik Fyrwald
Independent Director
Jamere Jackson
Independent Director
Kimberly Johnson
Independent Director
William Kaelin
Independent Director
Marschall Runge
Independent Director
Gabrielle Sulzberger
Independent Director
Jackson Tai
Independent Director
Karen Walker
Declaration Date
Dividend Per Share
Ex-Div Date
06/29/2021
Dividend USD 0.85
08/12/2021
05/03/2021
Dividend USD 0.85
05/13/2021
12/14/2020
Dividend USD 0.85
02/11/2021
10/19/2020
Dividend USD 0.74
11/12/2020
07/15/2020
Dividend USD 0.74
08/13/2020
05/04/2020
Dividend USD 0.74
05/14/2020
12/16/2019
Dividend USD 0.74
02/13/2020
10/21/2019
Dividend USD 0.645
11/14/2019
06/19/2019
Dividend USD 0.645
08/14/2019
05/06/2019
Dividend USD 0.645
05/16/2019
12/19/2018
Dividend USD 0.645
02/14/2019
10/15/2018
Dividend USD 0.563
11/14/2018
06/18/2018
Dividend USD 0.563
08/14/2018
05/07/2018
Dividend USD 0.563
05/16/2018
12/11/2017
Dividend USD 0.563
02/14/2018
10/16/2017
Dividend USD 0.52
11/14/2017
06/19/2017
Dividend USD 0.52
08/11/2017
05/01/2017
Dividend USD 0.52
05/11/2017
12/13/2016
Dividend USD 0.52
02/13/2017
10/18/2016
Dividend USD 0.51
11/10/2016
About LLY
Eli Lilly and Company is engaged in drug manufacturing business. The Company discovers, develops, manufactures and markets products in two segments: human pharmaceutical products and animal health products. The Company's human pharmaceutical business segment sells medicines, which are discovered or developed by its scientists. Its animal health business segment develops, manufactures and markets products for both food animals and companion animals. The Company's human pharmaceutical products include endocrinology products, neuroscience products, oncology products, immunology products and cardiovascular products. The Company's animal health products segment includes products for food animals and products for companion animals. As of December 31, 2018, the Company manufactured and distributed its products through facilities in the United States, Puerto Rico and 14 other countries.

Webull offers kinds of Eli Lilly And Co stock information, including NYSE:LLY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LLY stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading LLY stock methods without spending real money on the virtual paper trading platform.